Avian Colibacillosis: Etiology, Clinical Signs, Diagnosis, and Control in Poultry

Abstract

Avian colibacillosis is a globally significant bacterial disease of poultry caused by avian pathogenic Escherichia coli (APEC). It manifests as a spectrum of localized and systemic infections, including respiratory tract disease, polyserositis, septicemia, and enteritis, leading to substantial economic losses through mortality, reduced productivity, and condemnation at slaughter [1, 2, 3]. The pathogen is characterized by a diverse array of serogroups, virulence-associated genes (VAGs), and increasing antimicrobial resistance (AMR), which complicates both treatment and control [4, 31]. This article provides a comprehensive, publication-grade review of the etiology, clinical presentation, diagnostic approaches, and integrated control strategies for avian colibacillosis, with emphasis on molecular epidemiology, resistance mechanisms, and alternative therapeutic interventions.

Introduction

Colibacillosis remains one of the most common infectious diseases in commercial poultry flocks worldwide [3, 35]. The condition is caused by avian pathogenic Escherichia coli (APEC), a subset of extraintestinal pathogenic E. coli (ExPEC) that possesses specific virulence traits enabling colonization and invasion beyond the intestinal tract [1, 22]. APEC infections can occur at any age but are most prevalent in young birds (1–14 days) and during the onset of lay [3]. The disease is frequently secondary to viral or mycoplasmal respiratory infections, immunosuppression, or environmental stressors [4, 3]. Understanding the complex interplay between host, pathogen, and management factors is essential for effective control. This review synthesizes current knowledge from peer-reviewed literature, incorporating recent advances in genomics, antimicrobial resistance surveillance, and vaccine development.

Etiology

Avian Pathogenic Escherichia coli (APEC)

APEC belongs to the species Escherichia coli, a Gram-negative, facultatively anaerobic bacillus of the family Enterobacteriaceae [3]. Unlike commensal E. coli, APEC strains harbor a repertoire of VAGs that facilitate extraintestinal infection [19, 27]. These include genes encoding adhesins (e.g., fimH, pap), iron acquisition systems (e.g., iroN, iutA, aerJ), protectins (e.g., iss, ompT), toxins (e.g., hlyF, vat), and colicin V plasmid-associated determinants [2, 19, 27]. The CoIV plasmid is frequently identified in APEC and carries multiple virulence genes contributing to pathogenicity [2].

Serogroups and Sequence Types

APEC isolates are classified into O-serogroups based on lipopolysaccharide (LPS) O-antigens. Commonly reported serogroups include O78, O2, O1, O25, O86, O8, and O88 [2, 5, 27]. A longitudinal study in Georgia, USA, found O78 as the most prevalent serogroup, followed by O25 and O86, using a newly developed multiplex PCR panel (Klao9-SeroPCR) [2]. Other studies in Brazil and India have identified O6-B2-ST73 and O84/O149, respectively [19, 28]. Sequence type (ST) analysis has revealed clonal lineages such as ST117 (O78:H4, O53:H4) and ST23 (O78:H4) associated with large outbreaks in Nordic countries [5]. The emergence of carbapenem-resistant APEC co-harboring mcr-1 (colistin resistance) in O78 ST95 isolates from broilers highlights the zoonotic potential of these strains [31].

Phylogenetic Groups

E. coli phylogroups are determined by Clermont triplex PCR or gyrA sequencing [29]. APEC isolates typically belong to phylogroups B2 and D, with some strains falling into groups A, B1, F, G, or cryptic lineages [2, 27, 29]. In a study from Mississippi, 93% of APEC from broiler breeders carried at least one AMR gene, with tetA most prevalent [27]. Phylogroup B2 is also dominant among human ExPEC, suggesting potential overlap [28].

Epidemiology

Prevalence and Risk Factors

The prevalence of avian colibacillosis varies by region, management system, and flock age. In Mozambique, Taunde et al. reported a 100% occurrence of characteristic fibrinous polyserositis among 49 broiler chickens from farms with manual and automatic systems [6]. In Pakistan, the prevalence of colistin-resistant E. coli in broiler chickens was 24.78% [4]. A study in Bangladesh found that 54.55% of broilers examined across 104 farms had colibacillosis lesions, with winter season identified as a significant risk factor [33]. Multivariate analysis has identified preceding viral respiratory infection as a significant risk (OR = 4.808), whereas daily removal of dead or diseased birds was protective (OR = 0.308) [4].

Transmission

Transmission occurs via aerogenous, alimentary, and, less commonly, transovarial routes [3]. Vertical transmission from parent flocks to progeny via eggs is a major mechanism for the spread of virulent APEC clones, as demonstrated in Finnish outbreaks where common ancestral flocks were identified [5]. Horizontal spread occurs through contaminated feed, water, litter, equipment, and personnel [3]. Co-infection with Enterococcus faecalis enhances APEC survival under iron-restricted conditions and increases virulence in an embryo lethality assay [23].

Clinical Signs

Clinical manifestations of avian colibacillosis depend on the route of infection, age of the bird, and concurrent diseases. The condition may present as acute, subacute, or chronic [3].

Respiratory Form

Chickens with respiratory colibacillosis exhibit dyspnea, rales, coughing, and nasal discharge. This form commonly follows infection with respiratory viruses such as infectious bronchitis virus or Mycoplasma gallisepticum [4, 3]. Airsacculitis is a frequent finding.

Septicemic Form

Acute septicemia is characterized by depression, anorexia, lethargy, ruffled feathers, and sudden death. Birds may show chicken e coli symptoms including fever, cyanosis, and diarrhea [6, 33]. Affected flocks often exhibit increased mortality within 3–5 days of exposure.

Enteric Form

Enteritis presents with profuse, foamy diarrhea, leading to dehydration and poor growth [3]. This form is more common in young chicks.

Localized Infections

Localized forms include omphalitis (yolk sac infection) in chicks, salpingitis in laying hens, cellulitis (characterized by subcutaneous fibrinonecrotic plaques), and synovitis/arthritis [3, 5, 33]. Yolk sac infection is often associated with contaminated hatcheries.

Subclinical Effects

In broiler breeders and layers, subclinical colibacillosis can cause decreased egg production, increased mortality, and femoral head necrosis [5, 27].

When a chicken has e. coli, the clinical picture typically involves a combination of respiratory distress, diarrhea, and systemic signs. Differential diagnosis must consider other bacterial infections such as fowl cholera (caused by Pasteurella multocida) and infectious coryza (Avibacterium paragallinarum), as well as viral diseases like avian influenza (see Avian Colibacillosis: Escherichia coli Infections in Poultry – Clinical Manifestations, Diagnosis, and Control).

Pathology

Gross Lesions

The hallmark lesion of avian colibacillosis is fibrinous polyserositis, affecting the pericardium (pericarditis), liver capsule (perihepatitis), and air sacs (airsacculitis) [6, 33]. Pericarditis appears as a thickened, opaque, and adherent pericardium. Perihepatitis is characterized by a fibrinous envelope covering the liver, often described as "glazed" [6]. Air sacs are thickened with caseous exudates. Other findings include hepatomegaly with white pinpoint foci (100% in a Mozambique study), splenomegaly, and fibrinous peritonitis [6]. In the enteric form, the intestines show congestion and catarrhal to hemorrhagic enteritis [3, 33]. Cellulitis presents as yellow, fibrino-necrotic plaques in the subcutaneous tissue of the thighs and abdomen.

Microscopic Lesions

Histopathology reveals fibrinoheterophilic inflammation with degenerative heterophils, macrophages, and plasma cells, often with coccobacillary bacterial aggregates [6]. Coagulative necrosis is noted in the spleen (28.6%), liver (24.5%), and intestines (22.4%) [6]. Immunohistochemical staining confirms the presence of E. coli antigen in affected tissues including liver, heart, spleen, lungs, and intestines [6].

Diagnosis

Diagnosis of avian colibacillosis is based on clinical signs, gross pathology, and laboratory confirmation. The following table outlines the principal diagnostic methods:

A suggested diagnostic workflow is presented in the Mermaid diagram below.

flowchart TD
    A[Suspected colibacillosis: clinical signs or mortality], > B[Necropsy: fibrinous polyserositis?]
    B, >|Yes| C[Collect liver, heart blood, bone marrow, air sacs]
    B, >|No| D[Consider other causes: e.g., fowl cholera, necrotic enteritis]
    C, > E[Microbiology: culture on MacConkey agar, biochemical ID]
    E, > F[E. coli confirmed?]
    F, >|Yes| G[PCR serogrouping and virulence gene detection]
    F, >|No| H[Consider other pathogens: Pasteurella, Salmonella, Mycoplasma]
    G, > I[Antimicrobial susceptibility testing (disk diffusion or MIC)]
    I, > J[Select appropriate antimicrobial or alternative therapy]
    I, > K[Optional: WGS for outbreak tracing and resistance surveillance]
    K, > L[Epidemiological analysis and biosecurity adjustments]
    J, > M[Treatment and follow-up monitoring]

Does chicken have e. coli? The definitive answer requires laboratory confirmation. However, a strong presumptive diagnosis can be made in birds with characteristic fibrinous polyserositis on necropsy, especially when concurrent respiratory disease is present [6, 33].

Treatment

Antimicrobial Therapy

Antimicrobial treatment of avian colibacillosis is guided by culture and susceptibility testing due to widespread AMR [4, 27]. Commonly used antibiotics include amoxicillin-clavulanic acid, cefotaxime, trimethoprim-sulfamethoxazole, and tetracyclines, but resistance rates are high. In a Pakistani study, 84.21% of colistin-resistant APEC were resistant to amoxicillin-clavulanic acid, 70.17% to cefotaxime, and 73.68% to trimethoprim-sulfamethoxazole [4]. Multidrug resistance (MDR) is reported in 10.71–100% of isolates depending on the region [27, 31].

Colistin, once a last-resort antibiotic, is now compromised by the emergence of mcr genes. The mcr-1 gene was detected in 42.1% of colistin-resistant E. coli from broilers in Pakistan, with mcr-2 in 14.03% [4]. Co-occurrence of mcr-1 and carbapenem resistance in APEC O78 ST95 has been reported in broilers, raising serious public health concerns [31].

Alternative and Phytotherapeutic Approaches

Given the rise in AMR, plant-derived compounds are being investigated as alternatives. Thymus vulgaris hydroethanolic extract showed antibacterial activity (MIC 5.46–10.93 mg/ml) against APEC, with synergistic effects when combined with ampicillin (4–8-fold reduction in MIC) [7]. Mechanistic studies demonstrated disruption of bacterial membranes, inhibition of proton pumps, catalase reduction, and biofilm inhibition (49–72%) [7]. Similarly, matrine and berberine hydrochloride (active ingredients from Sophora flavescens and Coptis chinensis) exhibited synergistic antibacterial activity against MDR APEC in vitro and reduced mortality in chickens [8]. Schisandrin A (100–200 mg/kg) ameliorated liver injury, reduced inflammatory cytokines, and improved tight junction protein expression in E. coli-challenged chickens [9]. Caffeic acid-grafted chitosan loaded quercetin (CA-g-CS/QR) enhanced bacterial cell wall disruption and biofilm disassembly compared to quercetin alone, and restored intestinal microbiota balance in broilers [10]. The Ilex rotunda-Cyperus rotundus herb pair extract (CIRC) reduced mortality from 60% (model group) to 30–45%, decreased blood bacterial load, and improved gut microbiome diversity [11]. A review of medicinal plants used for avian colibacillosis between 2016 and 2022 identified numerous species with in vitro and in vivo efficacy [12]. Additionally, green synthesized zinc oxide nanoparticles and plant growth-promoting rhizobacteria have shown antagonism against E. coli [13].

Control

Biosecurity and Management

Prevention of avian colibacillosis relies on strict biosecurity, good husbandry, and control of predisposing factors. Key measures include:

• All-in/all-out production systems
• Effective cleaning and disinfection between flocks
• Control of litter moisture and ammonia levels
• Adequate ventilation to minimize respiratory stressors
• Vaccination against primary respiratory viruses (e.g., infectious bronchitis, Newcastle disease) and Mycoplasma species
• Monitoring and treatment of drinking water quality
• Daily removal of dead and moribund birds [4, 3]

Vaccination

Vaccination strategies for avian colibacillosis are evolving. Current options include:

• Inactivated (bacterin) vaccines: These are serotype-specific and have limited cross-protection [14, 24].
• Bivalent vaccines: An oil-adjuvanted vaccine targeting necrotic enteritis (Clostridium perfringens) and colibacillosis has been developed [15].
• Bacterial ghost vaccines: E. coli O78:K80 ghosts generated by E-lysis plasmid induced significant reduction in air sac lesions and elevated IFNγ, IgA, and IgY levels in broilers [24].
• Membrane vesicle (MV) vaccines: MVs derived from an LPS-low-expressing APEC mutant (FY26ΔmsbB) using nitrogen cavitation provided cross-protection against multiple serogroups (O1, O7, O45, O78, O101) [14].
• Recombinant attenuated Salmonella vaccines (RASVs): RASVs delivering APEC antigens (e.g., ecp operon) primed the immune system and reduced bacterial loads after APEC challenge, though heterologous protection was variable [34].

A postbiotic containing saponin, with or without vaccination, has also been evaluated for mitigation of colibacillosis [21].

Antimicrobial Stewardship

Reducing the selective pressure for AMR is critical. This involves prudent use of antibiotics, avoidance of prophylactic use, and reliance on culture-guided therapy [4, 3]. The detection of colistin-resistant APEC emphasizes the need for alternatives and robust surveillance [4, 31].

Conclusion

Avian colibacillosis remains a complex and economically devastating disease of poultry worldwide. The pathogen APEC is highly diverse, with shifting serogroup prevalence and increasing antimicrobial resistance, including to critically important antibiotics. Diagnosis requires a combination of gross pathology, bacteriology, and molecular tools. Treatment is increasingly complicated by MDR, but phytotherapeutics and novel vaccine platforms offer promising avenues for sustainable control. Integrated management programs that combine biosecurity, vaccination, and antimicrobial stewardship are essential to reduce the impact of colibacillosis and mitigate zoonotic risks.

References

[1] Runcharoon, K., Favro, M. E., Logue, C. M. The Pathogenicity Traits of Avian Pathogenic E. coli (APEC) O25-ST131 Associated with Avian Colibacillosis in Georgia Poultry and their Genotypic and Phenotypic Overlap with other ExPEC. Journal of Applied Microbiology, 2025. Link

[2] Runcharoon, K., Favro, M. E., Logue, C. M. Longitudinal analysis of avian pathogenic Escherichia coli (APEC) serogroups and pathotypes from avian colibacillosis in Georgia: A continued investigation – year 2 analysis. Poultry Science, 2024. Link

[3] Gerasimova, A. O., Novikova, O. B., Savicheva, A. A. Avian colibacillosis – current aspects. Veterinary Science Today, 2023. Link

[4] Saeed, M. A., Asif, H., Ehtisham-Ul-Haque, S., et al. Detection and risk factor analysis of avian colibacillosis associated with colistin-resistant Escherichia coli and Klebsiella pneumoniae. Frontiers in Veterinary Science, 2025. Link

[5] Biström, M., Vennerström, P., Lienemann, T., et al. Genomic epidemiology of avian pathogenic Escherichia coli in two broiler colibacillosis outbreaks in Finland. Veterinary Microbiology, 2025. Link

[6] Taunde, P., Bianchi, M., Mathai, V. M., et al. Pathological, microbiological and immunohistochemical characterization of avian colibacillosis in broiler chickens of Mozambique. Pesquisa Veterinária Brasileira, 2021. Link

[7] Saci, S., Nabti, E., Sebbane, H., et al. Exploring Thymus vulgaris Extract as a Phytotherapeutic Agent: A Multifaceted Approach to tackle Avian Colibacillosis and Drug Resistance. Poultry Science, 2025. Link

[8] Meng, J., Wang, W., Ding, J., et al. The synergy effect of matrine and berberine hydrochloride on treating colibacillosis caused by an avian highly pathogenic multidrug-resistant Escherichia coli. Poultry Science, 2024. Link

[9] Bao, J., Zhang, Y., Zhang, L., et al. Therapeutic effect of Schisandrin A on avian colibacillosis through gut-liver axis. Poultry Science, 2021. [Link](https://www.semanticscholar.org/paper/ce184595cbae250e0bdf2edb

[10] Ren, X., Yuan, S., Ren, J., et al. Effect of caffeic acid grafted chitosan loaded quercetin lyophilized powder formulation on avian colibacillosis and tissue distribution. Frontiers in Veterinary Science, 2024. Link

[11] Liu, H., Yang, A., Wei, X., et al. Preventive effects and underlying mechanisms of Ilex rotunda Thunb.-Cyperus rotundus L. herb pair extract on avian colibacillosis in chickens. Poultry Science, 2026. Link

[12] Kamil, M., Abu-Bakar, L., Reduan, M. H. F., et al. The Use of Medicinal Plants in Avian Colibacillosis Management: A Review. Veterinary Integrative Sciences, 2023. Link

[13] Masood, K., Yasmin, H., Batool, S., et al. A strategy for mitigating avian colibacillosis disease using plant growth promoting rhizobacteria and green synthesized zinc oxide nanoparticles. Saudi Journal of Biological Sciences, 2021. Link

[14] Zhu, D., Zhang, Y., Wang, Z., et al. Exploiting membrane vesicles derived from avian pathogenic Escherichia coli as a cross-protective subunit vaccine candidate against avian colibacillosis. Poultry Science, 2024. Link

[15] Indrawati, A., Safika, S., Nugroho, C., et al. Development and Evaluation of a Bivalent Oil-Adjuvanted Vaccine Against Necrotic Enteritis and Avian Colibacillosis in Poultry. Advances in Animal and Veterinary Sciences, 2025. Link

[16] Zhang, J., Cherbuin, J. D. R., Khan, M., et al. Complete genome sequences of three avian pathogenic Escherichia coli strains isolated from colibacillosis-affected poultry in Pakistan. Microbiology Resource Announcements, 2025. Link

[17] Saliha, U., Tivendale, K. A., Noormohammadi, A. H., et al. Nebulization as a more efficient method than atomizer for experimental reproduction of avian colibacillosis in young chickens. Avian Pathology, 2022. Link